Glenmark Pharmaceuticals Limited (GLENMARK.BO)
INR 1541.0
(1.1%)
INR 1541.0
(1.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 118.13 Billion | 127.25 Billion | 121.74 Billion | 108.06 Billion | 103.97 Billion | 97.05 Billion |
| Cost of Revenue | 48.79 Billion | 48.83 Billion | 47.78 Billion | 39.96 Billion | 40.35 Billion | 37.64 Billion |
| Gross Profit | 69.34 Billion | 78.42 Billion | 73.96 Billion | 68.09 Billion | 63.62 Billion | 59.41 Billion |
| Operating Expenses | 67.56 Billion | 61.73 Billion | 55.55 Billion | 50.93 Billion | 50.8 Billion | 46.81 Billion |
| Selling, General and Administrative Expenses | 33.36 Billion | 14.58 Billion | 12.97 Billion | 12.6 Billion | 13.7 Billion | 11.46 Billion |
| Research and Development Expenses | 12.25 Billion | 12.5 Billion | 12.78 Billion | 13.18 Billion | 13.2 Billion | 14.48 Billion |
| Other Expenses | 8.39 Billion | 712.92 Million | 688.35 Million | 468.65 Million | 162.93 Million | 267.61 Million |
| Cost and Expenses | 111.62 Billion | 110.56 Billion | 103.34 Billion | 90.89 Billion | 91.15 Billion | 84.45 Billion |
| Operating Income | 6.5 Billion | 17.12 Billion | 18.82 Billion | 16.65 Billion | 12.14 Billion | 15.89 Billion |
| Interest Expense | 5.15 Billion | 3.49 Billion | 2.98 Billion | 3.53 Billion | 3.77 Billion | 3.34 Billion |
| Income Tax Expense | 18.67 Billion | 4.91 Billion | 4.47 Billion | 4.12 Billion | 3.2 Billion | 3.75 Billion |
| Earnings before Tax | 364.95 Million | 8.68 Billion | 14.41 Billion | 13.82 Billion | 10.96 Billion | 13 Billion |
| Net Income | -15.01 Billion | 2.97 Billion | 9.41 Billion | 9.7 Billion | 7.75 Billion | 9.24 Billion |
| Earnings Per Share Basic | -53.22 | 10.53 | 33.37 | 34.38 | 27.50 | 32.78 |
| Earnings Per Share Diluted | -53.22 | 10.53 | 33.37 | 34.38 | 27.50 | 32.78 |
| Weighted Average Shares Outstanding | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 282.17 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.17 Million |
| Gross Margin | 0.59 | 0.62 | 0.61 | 0.63 | 0.61 | 0.61 |
| EBIT Margin | 0.10 | 0.20 | 0.20 | 0.20 | 0.18 | 0.18 |
| Profit Margin | -0.13 | 0.02 | 0.08 | 0.09 | 0.07 | 0.10 |
| EBITDA | 11.34 Billion | 11.58 Billion | 22.26 Billion | 21.79 Billion | 18.9 Billion | 15.85 Billion |
| Earnings Before Tax Margin | 0.06 | 0.13 | 0.15 | 0.15 | 0.12 | 0.16 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 32.44 Billion | 118.13 Billion | 30.62 Billion | 24.6 Billion | 31.6 Billion | 33.36 Billion |
| Cost of Revenue | 19.38 Billion | 78.63 Billion | 18.47 Billion | 10.32 Billion | 11.97 Billion | 12.27 Billion |
| Gross Profit | 13.05 Billion | 39.49 Billion | 12.15 Billion | 14.28 Billion | 19.62 Billion | 21.08 Billion |
| Operating Expenses | 8.35 Billion | 33.36 Billion | 8.62 Billion | 17.83 Billion | 16.42 Billion | 16.31 Billion |
| Selling, General and Administrative Expenses | 8.35 Billion | - | 8.62 Billion | 9.3 Billion | 8.14 Billion | 8.12 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 314.92 Million | 8.39 Billion | 7.73 Billion | 454.1 Million | 16.97 Million | 208.72 Million |
| Cost and Expenses | 27.73 Billion | 111.99 Billion | 27.09 Billion | 28.16 Billion | 28.39 Billion | 28.59 Billion |
| Operating Income | 4.7 Billion | 6.13 Billion | 3.53 Billion | -3.1 Billion | 3.2 Billion | 4.76 Billion |
| Interest Expense | 395.82 Million | 5.15 Billion | 1.48 Billion | 1.34 Billion | 1.21 Billion | 1.12 Billion |
| Income Tax Expense | 1.22 Billion | 18.67 Billion | 17.69 Billion | -718.01 Million | 559.46 Million | 1.6 Billion |
| Earnings before Tax | 4.62 Billion | 364.95 Million | 5.3 Billion | -5.21 Billion | -1.24 Billion | 3.33 Billion |
| Net Income | 3.4 Billion | -15.01 Billion | -12.18 Billion | -3.51 Billion | -819.45 Million | 1.49 Billion |
| Earnings Per Share Basic | 12.06 | - | -43.18 | -12.45 | -2.90 | 5.31 |
| Earnings Per Share Diluted | 12.06 | - | -43.18 | -12.45 | -2.90 | 5.31 |
| Weighted Average Shares Outstanding | 282.19 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 282.19 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million | 282.16 Million |
| Gross Margin | 0.40 | 0.33 | 0.40 | 0.58 | 0.62 | 0.63 |
| EBIT Margin | 0.18 | - | 0.16 | -0.07 | 0.15 | 0.20 |
| Profit Margin | 0.10 | -0.13 | -0.40 | -0.14 | -0.03 | 0.04 |
| EBITDA | 5.88 Billion | - | 5.04 Billion | -1.63 Billion | 4.63 Billion | 6.52 Billion |
| Earnings Before Tax Margin | 0.15 | 0.05 | 0.12 | -0.13 | 0.10 | 0.14 |
BPCR
COTQF
RNC
SHAHFOOD
0I14
AZM